What are alternatives to BPC 157?
Sources:
As BPC 157 becomes less available, alternatives are emerging, notably the peptide Pentadeca arginate (PDA). This new compound has a similar structure to BPC 157, differing by a single amino acid substitution and is showing promising clinical responses, particularly in reducing inflammation associated with injuries. Initial dosages for PDA recommended by include 250 to 500 micrograms daily, typically injected five days a week with two days off 1.
Additionally, within the realm of peptide therapeutics, there are several other potential alternatives:
- Thymosin Alpha: Known for its immune-modulating effects and benefits in tissue repair.
- Ipamorelin: A growth hormone releasing peptide that can enhance recovery and tissue repair.
- TB-500 (Thymosin Beta-4): Another peptide recognized for promoting healing and reducing inflammation in muscle and tissue injuries 1.
These alternatives share mechanisms that may help with similar therapeutic goals, such as promoting healing, reducing inflammation, and enhancing recovery abilities. However, as with any peptide therapy, it is crucial to consult a healthcare professional to determine appropriate options and dosages tailored to individual needs.
RELATED QUESTIONS
